- The Wall Street Journal•6 hours ago
Investors may not be ready for the jolt that Donald Trump could give to some stocks next week.
With stocks hitting new record highs, you might think there???s nothing left to buy. But some of the biggest money managers beg to differ.
- Investor's Business Daily•yesterday
Momenta and Pfizer are unexpectedly giving Teva some breathing room on a generic version of MS drug Copaxone.
MYL : Summary for Mylan N.V. - Yahoo Finance
Mylan N.V. (MYL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||41.81 x 300|
|Ask||42.77 x 300|
|Day's Range||41.86 - 42.30|
|52 Week Range||33.60 - 50.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||84.17|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|